Advaxis(ADXS)

0.328 %

今开:0.309昨收:0.313
最高:0.3494最低:0.3051
涨停价:跌停价:
总市值:8104924

Advaxis的热门评论

汇众医疗04-01 15:10

【汇众医疗】几家生物技术公司癌症药物研发有所突破,股价上涨 $Autolus Therapeutics(AUTL)$ $Constellation Pharmaceuticals(CNST)$ 美国癌症研究协会数据显示,生物技术公司Advaxis、AUTL、CNST、DVAX、JNCE、NTGN和TROV在各自主打的癌症治疗药物研发方面均有所突破,股价上涨,发展态势良好。...

令狐不冲88803-14 17:16

ADXS, 反弹后形成了一个小平台,该平台破位,成挖坑之势,随后该股跳空启动,这种平台+破位+跳空=启动,是一般比较经典的小爆股模式。

Advaxis的最新评论

令狐不冲88803-14 17:16

ADXS, 反弹后形成了一个小平台,该平台破位,成挖坑之势,随后该股跳空启动,这种平台+破位+跳空=启动,是一般比较经典的小爆股模式。查看全文

Advaxis的公告

$Advaxis(ADXS)$ 8-K - Current report Filed: 2019-10-04 AccNo: 0001493152-19-015081 Size: 4 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Advaxis(ADXS)$ 8-K - Current report Filed: 2019-09-13 AccNo: 0001493152-19-014099 Size: 30 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接

$Advaxis(ADXS)$ 8-K - Current report Filed: 2019-09-09 AccNo: 0001493152-19-013867 Size: 170 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Advaxis(ADXS)$ 8-K - Current report Filed: 2019-09-06 AccNo: 0001493152-19-013811 Size: 30 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接

$Advaxis(ADXS)$ 8-K - Current report Filed: 2019-08-22 AccNo: 0001493152-19-013270 Size: 48 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Advaxis(ADXS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-07-31 AccNo: 0001387131-19-005574 Size: 130 KB 网页链接

$Advaxis(ADXS)$ 8-K - Current report Filed: 2019-07-31 AccNo: 0001493152-19-011414 Size: 35 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 9.01: Financial Statements and Exhibits 网页链接

$Advaxis(ADXS)$ 8-K - Current report Filed: 2019-07-25 AccNo: 0001493152-19-011146 Size: 825 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.03: Material Modifications to Rights of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibi...